Michael Madden

Michael Madden

Auto-generated profile, based on publicly available information

Michael Madden

Department of Chemistry and Biochemistry, University of South Carolina, Columbia, USA

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 October 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
EOEthan A. Older
Ethan A. Older
JZJian Zhang
Jian Zhang
ZFZachary E. Ferris
Zachary E. Ferris
DXDan Xue
Dan Xue
ZZZheng Zhong
Zheng Zhong
JLJie Li
Jie Li
The trillions of microorganisms inhabiting the human gut are intricately linked to human health. While specific microbes have been associated with diseases, microbial abundance alone cannot reveal the molecular mechanisms involved. One such important mechanism is the biosynthesis of functional metabolites. Here, we develop a biosynthetic enzyme-guided disease correlation approach to uncover microbial functional metabolites linked to disease. Applying this approach, we negatively correlate the expression of gut microbial sulfonolipid (SoL) biosynthetic enzymes to inflammatory bowel disease (IBD). Targeted chemoinformatics and metabolomics then confirm that SoL abundance is significantly decreased in IBD patient data and samples. In a mouse model of IBD, we further validate that SoL abundance is decreased while inflammation is increased in diseased mice. We show that SoLs consistently contribute to the immunoregulatory activity of different SoL-producing human microbes. We further reveal that sulfobacins A and B, representative SoLs, act on Toll-like receptor 4 (TLR4) and block lipopolysaccharide (LPS) binding, suppressing both LPS-induced inflammation and macrophage M1 polarization. Together, these results suggest that SoLs mediate a protective effect against IBD through TLR4 signaling and showcase a widely applicable biosynthetic enzyme-guided disease correlation approach to directly link the biosynthesis of gut microbial functional metabolites to human health.

20 May 2025 in Nature Chemistry
Verified
Journal Article
Closed access
PDF file
DXDan Xue
Dan Xue
HZHongbin Zou
Hongbin Zou
YQYanping Qiu
Yanping Qiu
WLWei Lv
Wei Lv
MMMichael D. Madden
Michael D. Madden
JLJie Li
Jie Li


6 July 2026 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
MMMichael Madden
Michael Madden
DXDan Xue
Dan Xue
MXMingming Xu
Mingming Xu
KHKatherine Holandez-Lopez
Katherine Holandez-Lopez
JBJoseph Budiselich
Joseph Budiselich
JLJie Li
Jie Li
Streptomyces use small molecules to dictate morphological development and secondary metabolism. Most of these signaling compounds are inducers derived from γ-butyrolactone (GBL)-synthesizing enzymes. As such, biosynthetically distinct and downregulatory signaling molecules remain understudied in Streptomyces . Here, we report the identification of alkyloxaozle (AOX, 1 ), a downregulator of sporulation and antibiotic production in Streptomyces . 1 ’s structure features an oxazole head flanked by an alkyl tail synthesized by a nonribosomal peptide synthetase (NRPS) that has not been reported in Streptomyces signaling molecules. Functional studies found that 1 downregulated sporulation and secondary metabolism in several Streptomyces strains. Genome mining identified 45 homologous biosynthetic gene clusters (BGCs) only distributed in Streptomyces , underscoring the importance of AOXs to this productive genus. Altogether, this report presents a downregulatory class of signaling molecules that broadly affect Streptomyces and highlights their importance to the genus.

2 August 2024
Verified
Book
Closed access
CPConor Pulliam
Conor Pulliam
MMMichael Madden
Michael Madden
ACAndrew Campbell
Andrew Campbell
JLJie Li
Jie Li